LOGIN
TEAM
CONTACT US
COLLECTIONS
Bladder
Breast
Leukemia
Liver
Sarcoma
HOME
You need to enable JavaScript to run this app page.
Breast
BCM-15051
Model Details
Patient
PDX Model
Histology
Metastasis
Patient Treatment
Patient Information for Model: BCM-15051
Patient Information
Clinical Timeline
Color Keys:
Positive
Negative
N/A
Clinical Information at Collection
Clinical Biomarkers/Mutations at Collection
Pathology Information at Collection
Model Information for Model: BCM-15051
Model Details - Initial Implantation of Patient Tissue
Biomarkers & Mutations
Model Details - Acceptable Conditions for Passaging
Mutations (Cancer Gene Census List)
Show/Hide Columns
The number of models in this collection with mutations in the listed gene;
may include models that are not publicly available for distribution.
The number of models in this collection with mutations at the listed site;
may include models that are not publicly available for distribution.
Total mutations showing: 51
F
P
1
2
3
4
N
E
Rows Per Page
10
15
25
50
Download
Gene
Filter by Gene
Chr
Filter by Chr
Start
End
Ref
Alt
cDNA Change
Codon Change
Protein Change
TVAF
Gene Mutation Freq.
Site Mutation Freq.
Most Severe Effect
All Effects
Mutation Impact
Transcript ID
ClinVar Clinical Significance
COSMIC ID
gnomAD Non-Cancer AF
dbSNP ID
Gene Mutation Freq.
Site Mutation Freq.
Transcript ID
ClinVar Clinical Significance
COSMIC ID
dbSNP ID
AKAP9
chr7
92022864
92022864
A
AAAC
c.4004_4006dup
aaa/aAACaa
p.K1335_L1336insQ
0.976
50
35
In-frame Insertion
In-frame Insertion
MODERATE
ENST00000356239.8
COSV62337888
rs10644111
50
35
ENST00000356239.8
COSV62337888
rs10644111
AR
chrX
67546514
67546514
T
TGGC
c.1418_1420dup
-/GGC
p.G473dup
0.832
48
8
In-frame Insertion
In-frame Insertion
MODERATE
ENST00000374690.9
COSV104687717
48
8
ENST00000374690.9
COSV104687717
ARNT
chr1
150817408
150817408
C
T
c.1531G>A
Gac/Aac
p.D511N
0.394
5
2
Missense Variant
Missense Variant
MODERATE
ENST00000358595.10
Benign
0.005402390000
rs1805133
5
2
ENST00000358595.10
Benign
rs1805133
ATRX
chrX
77682471
77682471
C
G
c.2785G>C
Gag/Cag
p.E929Q
0.364
59
56
Missense Variant
Missense Variant
MODERATE
ENST00000373344.10
Benign
rs3088074
59
56
ENST00000373344.10
Benign
rs3088074
BAZ1A
chr14
34800248
34800248
C
G
c.1104G>C
gaG/gaC
p.E368D
0.98
9
2
Missense Variant
Missense Variant
MODERATE
ENST00000360310.6
rs1773618060
9
2
ENST00000360310.6
rs1773618060
BCR
chr22
23182000
23182000
C
T
c.1040C>T
tCt/tTt
p.S347F
0.978
7
2
Missense Variant
Missense Variant
MODERATE
ENST00000305877.13
7
2
ENST00000305877.13
CIITA
chr16
10907834
10907834
C
T
c.2345C>T
tCg/tTg
p.S782L
0.992
85
2
Missense Variant
Missense Variant
MODERATE
ENST00000618327.4
Benign
COSV60855363
0.062111600000
rs13330686
85
2
ENST00000618327.4
Benign
COSV60855363
rs13330686
CIITA
chr16
10909070
10909070
A
G
c.2702A>G
cAg/cGg
p.Q901R
0.967
85
84
Missense Variant
Missense Variant
MODERATE
ENST00000618327.4
Benign
0.983235000000
rs7197779
85
84
ENST00000618327.4
Benign
rs7197779
CIITA
chr16
10907837
10907837
T
C
c.2348T>C
gTg/gCg
p.V783A
0.981
85
2
Missense Variant
Missense Variant
MODERATE
ENST00000618327.4
Benign
COSV60855512
0.062202200000
rs13336804
85
2
ENST00000618327.4
Benign
COSV60855512
rs13336804
CREB3L2
chr7
137928167
137928170
CTGG
C
c.299_301del
aCCAgt/agt
p.T100del
0.375
49
49
In-frame Deletion
In-frame Deletion
MODERATE
ENST00000330387.11
COSV57791862
rs3217268
49
49
ENST00000330387.11
COSV57791862
rs3217268
ERCC2
chr19
45351661
45351661
T
G
c.2251A>C
Aag/Cag
p.K751Q
0.368
48
46
Missense Variant
Missense Variant
MODERATE
ENST00000391945.10
Benign/Likely_benign
COSV67266431
0.322955000000
rs13181
48
46
ENST00000391945.10
Benign/Likely_benign
COSV67266431
rs13181
EZH2
chr7
148828812
148828812
C
G
c.553G>C
Gac/Cac
p.D185H
0.286
13
12
Missense Variant
Missense Variant
MODERATE
ENST00000320356.7
Benign
COSV57449162
0.078149200000
rs2302427
13
12
ENST00000320356.7
Benign
COSV57449162
rs2302427
FAM47C
chrX
37009783
37009783
G
T
c.1373G>T
cGg/cTg
p.R458L
0.035
14
7
Missense Variant
Missense Variant
MODERATE
ENST00000358047.5
0.000123073000
rs200849623
14
7
ENST00000358047.5
rs200849623
FANCF
chr11
22624823
22624823
C
T
c.988G>A
Gag/Aag
p.E330K
0.446
4
2
Missense Variant
Missense Variant
MODERATE
ENST00000327470.6
4
2
ENST00000327470.6
GNAS
chr20
58855157
58855157
C
T
c.1892C>T
tCg/tTg
p.S631L
0.409
15
2
Missense Variant
Missense Variant
MODERATE
ENST00000371100.8
15
2
ENST00000371100.8
Total mutations showing: 51
F
P
1
2
3
4
N
E
Rows Per Page
10
15
25
50
Download
CNV
Histology Information for Model: BCM-15051
Patient
PDX
ER
H&E
HER2
PR
Metastasis Information for Model: BCM-15051
Patient
PDX
Abdomen
Abdominal cavity
Adrenal Gland
Anterosuperior mediastinum
Ascites
Axillary Lymph Node
Bone
Brain
CTC
Chest
Chest wall
Contralateral Breast
Fallopian tubes
Head
Hilar Node
Hip
Kidney
Leg bone
Leptomeninges
Liver
Lung
Lymph Node
Mediastinum
Metastasis Pleura
Neck
None
Other
Ovary
Pancreas
Paratracheal adenopathy
Pericardium
Peritoneal cavity
Peritoneum
Pleura
Pleural cavity
Pleural effusion
Posterior cervical nodes
Pulmonary
Retrocrural Lymph Node
SVC node
Sacral Spine
Skin
Spine
Spleen
Thymus
Patient Treatment Information for Model: BCM-15051
Event Id
Treatment
Treatment Setting
Age at Start
Age at End
Duration
Clinical Response
Reason Stopped
6
[Paclitaxel, Carboplatin]
Neoadjuvant
59.49
59.73
88 days
Treatment Completed
12
[Doxorubicin, Cyclophosphamide]
Neoadjuvant
59.8
59.84
15 days
Progressive Disease
Disease Progression
16
[Radiation Therapy (RT)]
Adjuvant
60.0
0.0
Unknown
Current Treatment
Timeout
Your session is about to expire. Click 'Stay Connected' to continue the session.
Stay Connected